Ultra-low dose of intravitreal bevacizumab in retinopathy of prematurity

ConclusionsThe low dose (0.0625  mg) of IVB treatment was effective as full (0.625 mg) dose in ROP treatment. Moreover, our results showed that low-dose treatment might provide faster retinal vascularization than the regular used dose. On the other hand, disappearance of the plus sign takes longer time in patients treated with l ow dose compared to eyes treated with full dose of IVB that should be taken into account.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research